Catalyzing Change: Educating Healthcare Stakeholders on Pharmacist Care Programs
July 1st 2009A multistakeholder, statewide symposium demonstrated the value of innovative pharmacist-led patient care programs and generated 9 key measures for planning or examining such programs.
Predictors of Response to Anti-Tumor Necrosis Factor Alpha Therapies in Rheumatoid Arthritis
July 1st 2009Methotrexate >15 mg weekly and adalimumab as first-line therapy were positive predictors of anti-TNF-a response in patients with rheumatoid arthritis.
Value-Based Health Design: Putting the Patient at the Center
July 1st 2009Ms Nayer praises the bold collaborations between pharmaceutical companies and health plans that base contract incentives on improving health outcomes, not the volume of drugs sold.